超越医疗疗法 - - 关于心力衰竭设备的最新消息
Luigi Falco1, Fabio Valente1, Aldo De Falco1
1Heart Failure Unit, Department of Cardiology, AORN dei Colli-Monaldi Hospital, 80131 Naples, Italy.
Journal of cardiovascular development and disease
|July 26, 2024
概括
心力衰竭 (HF) 管理需要创新,而不仅仅是指导方针导向医学治疗 (GDMT). 本审查更新了针对高频率的新型设备的最新情况.
科学领域:
- 心脏病学 心脏病学
- 生物医学工程 生物医学工程
- 翻译医学是一种翻译医学.
背景情况:
- 心力衰竭 (HF) 呈现出显著的发病率,死亡率和生活质量 (QoL) 的降低.
- 尽管指南导向医学疗法 (GDMT) 和最近的临床试验进展,死亡率仍然很高,住院病例正在增加.
- 在HF患者中仍然存在相当大的残留风险,需要新的治疗策略.
研究的目的:
- 为心力衰竭 (HF) 管理提供创新设备的最新概述.
- 审查目前已批准的和正在研究的针对HF的膜,结构和自主异常的设备.
- 突出用于解决HF治疗未满足需求的设备开发的翻译性进展.
主要方法:
- 对最近的大规模随机临床试验 (RCT) 的系统文献综述.
- 对高频的已批准和新兴设备技术的分析.
- 专注于解决膜,结构和自主功能障碍的设备.
主要成果:
- 最近的治疗进步扩大了治疗选择,但并没有阻止死亡率和住院病例的增加.
- 单靠指南导向医学疗法 (GDMT) 就会在心力衰竭患者中留下显著的残留风险.
- 针对特定高频病理的新型设备至关重要,正在积极开发中.
结论:
- 基于设备的创新疗法对于解决心力衰竭 (HF) 管理的持续挑战至关重要.
- 设备开发的翻译性推动为治疗HF提供了有希望的新途径.
- 本综述巩固了关于已批准和正在研究的器械的当前知识,指导了未来的临床实践和研究.
更多相关视频
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.5K
07:24Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
24.2K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
01:26Heart Failure Drugs: Inotropic Agents
555
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
555
01:22Heart Failure Drugs: Diuretics
355
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
355
01:22Heart Failure Drugs: β-Blockers
332
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
332
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.2K